Literature DB >> 18156175

An integrin phosphorylation switch: the effect of beta3 integrin tail phosphorylation on Dok1 and talin binding.

Camilla L Oxley1, Nicholas J Anthis, Edward D Lowe, Ioannis Vakonakis, Iain D Campbell, Kate L Wegener.   

Abstract

Integrins play a fundamental role in cell migration and adhesion; knowledge of how they are regulated and controlled is vital for understanding these processes. Recent work showed that Dok1 negatively regulates integrin activation, presumably by competition with talin. To understand how this occurs, we used NMR spectroscopy and x-ray crystallography to investigate the molecular details of interactions with integrins. The binding affinities of beta3 integrin tails for the Dok1 and talin phosphotyrosine binding domains were quantified using 15N-1H hetero-nuclear single quantum correlation titrations, revealing that the unphosphorylated integrin tail binds more strongly to talin than Dok1. Chemical shift mapping showed that unlike talin, Dok1 exclusively interacts with the canonical NPXY motif of the beta3 integrin tail. Upon phosphorylation of Tyr 747 in the beta3 integrin tail, however, Dok1 then binds much more strongly than talin. Thus, we show that phosphorylation of Tyr 747 provides a switch for integrin ligand binding. This switch may represent an in vivo mechanism for control of integrin receptor activation. These results have implications for the control of integrin signaling by proteins containing phosphotyrosine binding domains.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18156175     DOI: 10.1074/jbc.M709435200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Syndecan-1 couples the insulin-like growth factor-1 receptor to inside-out integrin activation.

Authors:  DeannaLee M Beauvais; Alan C Rapraeger
Journal:  J Cell Sci       Date:  2010-11-01       Impact factor: 5.285

Review 2.  Linking integrin conformation to function.

Authors:  Janet A Askari; Patrick A Buckley; A Paul Mould; Martin J Humphries
Journal:  J Cell Sci       Date:  2009-01-15       Impact factor: 5.285

Review 3.  Integrin signalling at a glance.

Authors:  David S Harburger; David A Calderwood
Journal:  J Cell Sci       Date:  2009-01-15       Impact factor: 5.285

Review 4.  Integrin inactivators: balancing cellular functions in vitro and in vivo.

Authors:  Daniel Bouvard; Jeroen Pouwels; Nicola De Franceschi; Johanna Ivaska
Journal:  Nat Rev Mol Cell Biol       Date:  2013-05-30       Impact factor: 94.444

Review 5.  Talin and Kindlin as Integrin-Activating Proteins: Focus on the Heart.

Authors:  Chao Chen; Ana Maria Manso; Robert S Ross
Journal:  Pediatr Cardiol       Date:  2019-07-31       Impact factor: 1.655

6.  The structure of an integrin/talin complex reveals the basis of inside-out signal transduction.

Authors:  Nicholas J Anthis; Kate L Wegener; Feng Ye; Chungho Kim; Benjamin T Goult; Edward D Lowe; Ioannis Vakonakis; Neil Bate; David R Critchley; Mark H Ginsberg; Iain D Campbell
Journal:  EMBO J       Date:  2009-10-01       Impact factor: 11.598

7.  Beta integrin tyrosine phosphorylation is a conserved mechanism for regulating talin-induced integrin activation.

Authors:  Nicholas J Anthis; Jacob R Haling; Camilla L Oxley; Massimiliano Memo; Kate L Wegener; Chinten J Lim; Mark H Ginsberg; Iain D Campbell
Journal:  J Biol Chem       Date:  2009-10-20       Impact factor: 5.157

Review 8.  Transdominant regulation of integrin function: mechanisms of crosstalk.

Authors:  Annette M Gonzalez; Ramona Bhattacharya; Gregory W deHart; Jonathan C R Jones
Journal:  Cell Signal       Date:  2009-10-27       Impact factor: 4.315

Review 9.  Immunopathologies linked to integrin signalling.

Authors:  Hongyan Wang; Daina Lim; Christopher E Rudd
Journal:  Semin Immunopathol       Date:  2010-03-10       Impact factor: 9.623

10.  The structure of an interdomain complex that regulates talin activity.

Authors:  Benjamin T Goult; Neil Bate; Nicholas J Anthis; Kate L Wegener; Alexandre R Gingras; Bipin Patel; Igor L Barsukov; Iain D Campbell; Gordon C K Roberts; David R Critchley
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.